BSEInsider Trading / SAST31 Aug 2026 · 31 Aug 2026, 04:10 pm
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali
Asston Pharmaceuticals Ltd · 544445
✦ AI SummaryRelated Party
Asston Pharmaceuticals Ltd has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern3/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Asston Pharmaceuticals Ltd - 544445 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011